myriad genetics inc (MYGN:NASDAQ GS)
Mark H. Skolnick Ph.D.
Former Chief Scientific Officer and Director, Myriad Genetics Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 4 different industries.|
Mr. Mark H. Skolnick Ph.D. was a Scientific Founder of Myriad Genetics Inc. and served as its Chief Scientific Officer since 1997. Dr. Skolnick served as Executive Vice President of Research and Development of Myriad Genetics Inc. from 1991 to July 2000. Dr. Skolnick directed the group that cloned the breast cancer susceptibility gene, BRCA1; found the full-length sequence of BRCA2; cloned the MMAC1 (PTEN) tumor suppressor gene; cloned a prostate cancer gene (HPC2); ...
320 Wakara WayPhone: 801-584-3600
Salt Lake City, Utah 84108
Board Members Memberships*
Former Chief Scientific Officer and Director
University of California
University of California Berkeley
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Frank S. Hermance||Chairman, Chief Executive Officer and Chairman of Executive Committee|
|Jen-Hsun Huang||Co-Founder, Chief Executive Officer, President and Director|
|Moshe N. Gavrielov||Chief Executive Officer, President and Director|
|Robert J. Stanzione||Chairman and Chief Executive Officer|
ARRIS Group, Inc.
|Richard P. Wallace||Chief Executive Officer, President and Executive Director|
|$900.0K||Compensation as of Fiscal Year 2013.|